Super-responders to bidirectional neoadjuvant chemotherapy showed prolonged survival.

Super-responders to bidirectional neoadjuvant chemotherapy showed prolonged survival. - 2021


English

2078-6891

10.21037/jgo-2020-11 [doi] jgo-12-S1-S57 [pii] PMC8100712 [pmc]


IN PROCESS -- NOT YET INDEXED


Washington Cancer Institute


Comment
Editorial

Powered by Koha